Addiction Treatment Forum

Addiction Treatment Forum reports on substance abuse news of interest to opioid treatment programs and patients in medication-assisted treatment.

Addiction Treatment Forum reports on
substance use news of interest to
opioid treatment programs and patients
in medication-assisted treatment.

Follow Us

Follow us on Facebook Follow us on Twitter
  • Home
  • Newsletter
    • Newsletter Archives
  • News Updates
    • News Updates Archives
  • Addiction Resources
    • Addiction and Recovery
    • Addiction Treatment Forum
    • Books and Booklets of Interest
    • Drug Screening and Testing
    • Evidence-Based Addiction Medicine
    • Government
    • Health Care Reform
    • Hepatitis, HIV/AIDS
    • Medication-Assisted Treatment
    • Mental Health
    • Miscellaneous
    • Online Continuing Education Free Training Modules
    • Videos
  • Rx Methadone & Safety
  • Patient Brochures
  • Events
  • Clinic Locator
  • Related Websites
    • Accreditation Organizations
    • Associations
    • Government
    • International Organizations
    • Journals & Newsletters
    • Patient Advocacy and Self-Help Groups
    • Research/Reference
    • Treatment Facility Locators

Califf, FDA Top Officials Call for Sweeping Review of Agency Opioids Policies

February 16, 2016

FDAIn response to the opioid abuse epidemic, today Dr. Robert Califf, the FDA’s Deputy Commissioner for Medical Products and Tobacco, along with other FDA leaders, called for a far-reaching action plan to reassess the agency’s approach to opioid medications. The plan will focus on policies aimed at reversing the epidemic, while still providing patients in pain access to effective relief.

The FDA will:

  • Re-examine the risk-benefit paradigm for opioids and ensure that the agency considers their wider public health effects;
  • Convene an expert advisory committee before approving any new drug application for an opioid that does not have abuse-deterrent properties;
  • Assemble and consult with the Pediatric Advisory Committee regarding a framework for pediatric opioid labeling before any new labeling is approved;
  • Develop changes to immediate-release opioid labeling, including additional warnings and safety information that incorporate elements similar to the extended-release/long-acting (ER/LA) opioid analgesics labeling that is currently required;
  • Update Risk Evaluation and Mitigation Strategy requirements for opioids after considering advisory committee recommendations and review of existing requirements;
  • Expand access to, and encourage the development of, abuse-deterrent formulations of opioid products;
  • Improve access to naloxone and medication-assisted treatment options for patients with  opioid use disorders; and
  • Support better pain management options, including alternative treatments.

Read more at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm484765.htm

Source: Federal Drug Administration – February 4, 2016

See related news from the FDA: Fact Sheet – FDA Opioids Action Plan
available at: http://www.fda.gov/NewsEvents/Newsroom/FactSheets/ucm484714.htm

See related article from the Washington Post – We can do more,’ FDA says in announcing overhaul of approach to opioid painkillers available at: https://www.washingtonpost.com/news/to-your-health/wp/2016/02/04/we-can-do-more-fda-says-in-announcing-overhaul-of-its-approach-to-opioid-painkillers/

Categories: Addiction, News Updates, Opioid Abuse/Addiction, Opioids, Prescription Drugs
Tags: Methadone Treatment, naloxone, Opioid Treatment Programs, Overdose, Pain, Prescription Opioids

feedback
Your comments and feedback are important to us.

Current News Update

News & Updates – April 6, 2018; Issue 292

Current Newsletter

AT Forum Volume 29, #2 February/March 2018

Sign-up for e-mail notifications

Thanks for signing up!

© Copyright 2018 Addiction Treatment Forum · All Rights Reserved · About Us · Contact · Terms of Use · Privacy Policy